Cover image of Medtech Talk
(28)
Business
Investing
Health & Fitness

Medtech Talk

Updated about 1 month ago

Business
Investing
Health & Fitness
Read more

A weekly conversation with the innovators who will change how health care is delivered.

Read more

A weekly conversation with the innovators who will change how health care is delivered.

iTunes Ratings

28 Ratings
Average Ratings
20
5
2
0
1

Great podcast

By Catherine.cookie - Jul 13 2019
Read more
Great for anyone looking to learn more about medical technologies/ current Med tech news

Medtech Investor

By MJ12345! - Mar 14 2019
Read more
Love the interview content. Well rounded and interesting. Always learn something new

iTunes Ratings

28 Ratings
Average Ratings
20
5
2
0
1

Great podcast

By Catherine.cookie - Jul 13 2019
Read more
Great for anyone looking to learn more about medical technologies/ current Med tech news

Medtech Investor

By MJ12345! - Mar 14 2019
Read more
Love the interview content. Well rounded and interesting. Always learn something new
Cover image of Medtech Talk

Medtech Talk

Latest release on Jun 05, 2020

Read more

A weekly conversation with the innovators who will change how health care is delivered.

Rank #1: CEO Stevens Says HeartFlow Took No Shortcuts to Commercialization, Raising $240 million Series E

Podcast cover
Read more
John H. Stevens, MD, was too excited to sleep when he first heard what HeartFlow's technology could potentially do. Eight years later, he's sleeping a lot better, having secured $240 million to fund the company's commercial rollout of the HeartFlow Analysis system.

Overview: HeartFlow has built a strong financial argument for its imaging system.

Surprises: This stuff belongs on Star Trek. Very cool.

Takeaway: "There are no shortcuts."

Mar 06 2018

35mins

Play

Rank #2: Justin Klein, MD, JD, Partner at New Enterprise Associates

Podcast cover
Read more
Justin Klein, MD, JD, sits down with Healthegy TV to provide details on where his firm, New Enterprise Associates, sees the greatest opportunities in Medtech. He also explains how a firm with $3 billion to manage still makes early-stage investments.

Feb 29 2016

24mins

Play

Rank #3: HealthQuest’s Kong on teamwork, Medtech, and investing $225 million

Podcast cover
Read more
HealthQuest Capital secured a $225 million fund to invest in new health care technologies. Managing Director Garheng Kong, MD, explains the firm’s views on health care, how doctors view new technologies and what competitive volleyball can teach us about venture investing.

Mar 30 2016

26mins

Play

Rank #4: Relievant CEO Kevin Hykes Shares the Advice that Led Him to Set a Successful Course as CEO

Podcast cover
Read more
Under CEO Kevin Hykes, Relievant Medsystems is racking up some wins. The company closed on a $58 million Series E round last month and this week announced the first commercial application of its Intraspect pain-relief procedure. In this podcast, Hykes doles out some valuable career advice for wanna be CEOs and talks about the technology that could turn Relievant into a Medtech powerhouse.

Jul 13 2018

37mins

Play

Rank #5: Advice of the Valkyrie – GE Venture’s Lisa Suennen Explains How Medtechers Can Find Their Voice

Podcast cover
Read more
For more than a decade, Lisa Suennen, Senior Managing Director, healthcare at GE Ventures and Managing Partner at Venture Valkyrie, LLC, has blogged and opined on the healthcare industry. In this podcast she reveals what first led her to speak up and shares how Medtech execs can find their own voices. She also talks about CSweetner.org, a not-for-profit she created to help women executives rise to the C-suite.

Apr 06 2017

39mins

Play

Rank #6: Foundry’s Gifford: Innovating Innovation in a Changing Health Care World

Podcast cover
Read more
Hanson Gifford of The Foundry reviews the evolving challenges behind Medtech innovation and shares details on Fire1 and Ardian.

Apr 23 2015

27mins

Play

Rank #7: Stryker’s Kevin Lobo Explains Why He Calls Medtech Home, How the “Serial Acquirer” Will Keep Growing

Podcast cover
Read more

Growing up in Canada, Kevin Lobo only knew he wanted to be a senior executive at a global company someday. That overriding objective took him through the consumer good and chemical industries before the financial executive found his first job in Medtech. In this interview conducted at the Medtech Conference in Minneapolis, Lobo reveals that while he first was reluctant to take that Medtech job, he’s now grateful to have found a home. “If you’ve only been in Medtech, you do not understand how lucky you are to be in this industry.” Lobo shares insights on how he built a career that positioned him to lead one of Medtech’s giant. He also explains why under his watch Stryker grew to become a “serial acquirer” of that has spent $14 billion to acquire 55 companies during his tenure as CEO. 

Jun 17 2019

37mins

Play

Rank #8: SVB’s Jon Norris Reveals Medtech’s Most Prolific Investors, Hottest Areas, and Biggest Exits

Podcast cover
Read more

Earlier this month, Silicon Valley Bank released its Trends in Healthcare Investments and Exits 2019, the latest of the bank’s annual reports on the state of healthcare investing. In this podcast we talk with Report Guru (and Managing Director) Jonathan Norris about the top takeaways including:

  • What’s the emerging hot spot for Device Start-Ups?
  • What VCs are making Series A deals?
  • Are Angels and Crowdfunding groups making an impact?
  • How busy are Corporates?
  • What’s a Big Exit? And why are they on the rise?


You can download the report yourself here.

Join us at the Medtech Conference to hear Norris’ update on Medtech Funding

Jan 25 2019

40mins

Play

Rank #9: Stanford’s Yock Talks Medtech Costs, Biodesign’s Birthday, and How He Feels about Apple and Google

Podcast cover
Read more
Paul Yock, MD, started Stanford’s Byers Center for Biodesign to help teach innovation. While the idea didn’t excite everyone, the center has emerged as the hub of entrepreneurial excellence. Dr. Yock speaks to the role of innovation and how it impacts Medtech.

May 03 2017

25mins

Play

Rank #10: Managing Director Kirk Nielsen Talks Origins, Medtech, and Versant Ventures’ new $400 Million Fund

Podcast cover
Read more
Kirk Nielsen’s path to Versant passed through thoughts of medical school, a short stint in the NHL, and a span at Medtronic. Today, Nielsen represents the global VC’s interests in Medtech, serving as part of a new generation of partners taking over from the VC giant’s founders.

Mar 17 2017

29mins

Play

Rank #11: Propeller Health CEO David Van Sickle Explains How Sensors, Data Can Help Manage Respiratory Disease

Podcast cover
Read more
David Van Sickle, CEO & Co-Founder of Propeller Health, brings his public health background to health tech start-up Propeller Health. The company has created a line of sensors that work in conjunction with inhalers and spirometers to measure medication intake and breathing capacity of people with asthma. The start-up has undertaken some bold projects with entire cities including Louisville to demonstrate how tools such as these can benefit communities. In this podcast Van Sickle discusses the company's unique origins, its technology and a small hiccup involving the company's former name. Van Sickle will be speaking on an innovative panel at the May 31 Medtech Conference in Minneapolis.

May 11 2018

33mins

Play

Rank #12: How Will Abbott & Auris Deals Impact Early Stage Start-ups?

Podcast cover
Read more
Abbott’s move to acquire St. Jude demonstrates how Medtronic’s moves toward “Total Solutions” may change the game in Medtech. We’re going to tackle that topic at the June 1 Medtech Conference. Our conference co-chairs discuss that piece of our upcoming agenda as well as our focus on robotics.

May 03 2016

21mins

Play

Rank #13: Ceterix CEO John McCutcheon Is Writing a Different Ending with New Tech That Can Save the Meniscus

Podcast cover
Read more
In 2010, John McCutcheon joined Ceterix, a start-up with big goals and a surer FDA path than his previous company. McCutcheon recounts the FDA's battering of that company, Emphasys, and explains how his current company is rolling today.

Apr 26 2018

35mins

Play

Rank #14: How Will CEO Pavlidis Help VytronUS Deliver Disruptive Ultrasound Tool to Treat Afib in the EP Lab?

Podcast cover
Read more
John Pavlidis, president and CEO of VytronUS, has built a strong resume leading and selling Medtech start-ups. Now the self-described engineering “nerd” is leading VytronUS, a start-up combining the powers of imaging, ablation, and robotics to create a powerful new tool that can elevate the precision of treating atrial fibrillation in the electrophysiology lab.

Nov 03 2017

34mins

Play

Rank #15: SVB’s Numbers Guru Jon Norris Points to More Investors, Stronger Exits Facing Medtech in 2018

Podcast cover
Read more

Hard to find anyone working harder than Jonathan Norris to help us see the forest for the trees.

Jon is a fixture at many conferences including – thankfully – the upcoming Medtech Conference on May 31. But we wanted to get to his insights early. In this Medtech Talk Podcast, Jon and I discuss his report, “Trends in Healthcare Investments and Exits 2018.”

Overview: Jon shares some positive views for Medtech. Good to hear.
Surprises: I didn’t know Jon’s initial career choice.
Regrets: I didn’t get to ask how his pitching arm is doing. Jon still plays ball on a regular basis.

Enjoy the podcast!

Jan 29 2018

41mins

Play

Rank #16: FundRx Finding the Formula to Bring LPs, VCs, Individuals to Fund Promising Medtech Start-Ups

Podcast cover
Read more
Zeshan Muhammedi thinks he and his co-founders of FundRx have identified some “misalignments” in funding Medtechs. The solution may be FundRx, a new breed of venture capital firm bringing LPs, KOLs, and entrepreneurs on the same page.

Feb 24 2017

34mins

Play

Rank #17: Mylea Charvat Says Savonix Working to Turn Cognitive Function into Vital Measure

Podcast cover
Read more
Faced with an unacceptable diagnosis after her husband was seriously injured in an accident, Savonix CEO Mylea Charvat created a tool to measure cognitive function to aid his recovery. Now Savonix seeks to establish cognitive function as a standard measure of human health. The technology potentially could could fill a huge shortage of physicians while improving patient outcomes and accelerating medical innovation.

Oct 20 2017

39mins

Play

Rank #18: NxThera CEO Bob Paulson Talks M&A, Career Twists, Family, and Lessons Learned from Selling Yogurt

Podcast cover
Read more
Boston Scientific's acquisition of NxThera obviously signals an end of one era. The 10-year-old start-up will live inside the global giant, of course, but we ask CEO Bob Paulson what the sale means to him on a personal level. Paulson also walks us through his unorthodox career in marketing, corporate law, accounting, and finally leading a highly successful Medtech Start-Up.

May 07 2018

44mins

Play

Rank #19: Wahr says Nuvaira gives him a familiar feeling; lays out plans for fund-raising, commercial launch

Podcast cover
Read more
Nuvaira CEO Dennis Wahr, MD, sees similarities between interventional pulmonology today and interventional cardiology in its early days. He hopes Nuvaira, which is developing a tool to ablate lung tissue, will be able to further the field through upcoming clinical trials and fund-raising.

Oct 13 2017

29mins

Play

Rank #20: CEO John Pedersen Explains Why Urology – and Augmenix – Are Enjoying Such an “Interesting Time”

Podcast cover
Read more
In this Medtech Talk Podcast, CEO John Pedersen explains why he chose to help Augmenix roll out its SPACEOAR implant, a hydrogel that's inserted between a patient's prostate and rectum to save healthy tissue from radiation exposure. In this talk, Pedersen discusses the rise of urology - which includes the recent acquisitions of Neotract and NxThera. He also updates listeners on Augmenix's efforts to secure reimbursement. Finally, the former Boston Scientific exec offers advice to anyone working in a global Medtech company.

Jun 13 2018

27mins

Play

Episode 149: Ethical Leadership, Corporate Responsibility, and the Transformative Power of Yoga

Podcast cover
Read more

Mike Huggins is a leader in the medtech world whose journey from Synthes, USA COO to an indictment and prison sentence has run parallel to his discovery of yoga, mindfulness, and meditation, weaving together these experiences that have developed his passion for ethical leadership, corporate responsibility, prison reform, and the practices that have helped him along the way. 

Jun 05 2020

54mins

Play

Episode 148: Kaiser Permanente’s Liz Rockett on Her VC Career and Gender Inequality in the Industry

Podcast cover
Read more

As an English Major at Princeton, Liz Rockett could not have imagined how her VC career would take off and the places it would take her. She shares her candid career journey, from taking risks, asking questions, and using her voice to empower gender equality in the field. 

May 21 2020

52mins

Play

Episode 147: Leadership and Innovation to Combat a Global Pandemic

Podcast cover
Read more

Butterfly Network CEO Laurent Faracci shares his experience leading a company through the Coronavirus outbreak, while producing lifesaving technology to battle the crisis. Laurent joined Butterfly as the Coronavirus spread to a global pandemic level, but he isn’t slowing down. Under his leadership, Butterfly continues to grow as their cutting-edge ultrasound technology proves itself a leading advancement in the fight against the Coronavirus in a time where leadership and innovation are essential to the future of healthcare. 

May 07 2020

49mins

Play

Episode 146: Vapotherm CEO Joe Army: Wisdom from the Northern Kingdom to the Board Room and Beyond

Podcast cover
Read more

Joe Army’s career journey through the medtech industry has been anything but easy, but he does not back down from a challenge, and he’s sharing the greatest lessons that have helped him pave his own way. 

Apr 22 2020

57mins

Play

Episode 145: Medtech Talk Welcomes its New Host

Podcast cover
Read more

Medtech Talk welcomes its new host, Geoff Pardo! Geoff is a dynamic partner at Gilde Healthcare who uses his passion for medtech to share stories from industry leaders.  

Mar 27 2020

10mins

Play

Can New CEO Murthy Simhambhatla Help SetPoint Medical Deliver on Bioelectronics’ Promise?

Podcast cover
Read more

In this interview, Murthy Simhambhatla, president and CEO of SetPoint Medical, explains why he moved into the Medtech industry and how that path has positioned him to lead SetPoint Medical, one of the industry’s most promising start-ups. 

Dec 19 2019

46mins

Play

Where NeuroPace Is Headed Under New CEO Mike Favet

Podcast cover
Read more

In this episode, Mike Favet, the new CEO of NeuroPace, shares his personal story into Medtech and reveals his plans for one of Medtech’s pioneers, NeuroPace. What convinced him to become CEO? What changes will he make at NeuroPace?

Dec 10 2019

38mins

Play

How Frank Fischer and Martha Morrell, MD, Launched one of Medtech’s Pioneering Neurostim Companies

Podcast cover
Read more

In this interview, Frank Fischer and Martha Morrell, MD, recount the long history of NeuroPace, one of Medtech’s neurostimulation pioneers. 

Nov 27 2019

1hr 3mins

Play

Medtech CEO Duke Rohlen Grew Into His Name. Can AJAX Health Do the Same?

Podcast cover
Read more

In this episode of Medtech Talk, Duke Rohlen, CEO of AJAX Health, answers several critical questions about the importance of names. What’s his real name? Why is the AJAX name so important to him? And how did he employ “stair stepping” to make a name for himself in Medtech (before founding, funding and exiting several high profile start-ups.) 

Oct 17 2019

42mins

Play

CEO Kim Rodriguez Says Big Bet on Acessa Is Paying Off for Patients and Investors

Podcast cover
Read more

Kim Rodriguez expected to follow her mom’s career in medicine. But she got bit by the Medtech Bug early and enjoyed a string of sales success at companies of nearly every size including Cocentric, Spectranetics, and Guidant. But three years ago she got recruited to be CEO of a company that was rich in promising technologies as well as business challenges. In just three years, Rodriguez and her team at Acessa pulled out of the tail spin, secured FDA approval and a CPT code and now are building a promising women’s health company. In this episode, she’ll share how aspiring execs should ante up. 

Sep 20 2019

32mins

Play

Medtech VCs Klein, Nielsen Explain Why They Decided to Start Up Their Own Venture Firm, Vensana

Podcast cover
Read more

Justin Klein and Kirk Nielsen entered venture capital separately 13 years ago, taking roles at two of the top firms in Medtech. Over that time, the two VCs have led investment in more than a dozen Medtech companies that have either gone public or been acquired. Now, the pair have joined forces to create Vensana Capital, a new investor in Medtech. In this episode, you’ll hear why they decided to venture out on their own and where they’ll be investing $225 million in capital from their first fund.   

Sep 04 2019

37mins

Play

Stryker’s Kevin Lobo Explains Why He Calls Medtech Home, How the “Serial Acquirer” Will Keep Growing

Podcast cover
Read more

Growing up in Canada, Kevin Lobo only knew he wanted to be a senior executive at a global company someday. That overriding objective took him through the consumer good and chemical industries before the financial executive found his first job in Medtech. In this interview conducted at the Medtech Conference in Minneapolis, Lobo reveals that while he first was reluctant to take that Medtech job, he’s now grateful to have found a home. “If you’ve only been in Medtech, you do not understand how lucky you are to be in this industry.” Lobo shares insights on how he built a career that positioned him to lead one of Medtech’s giant. He also explains why under his watch Stryker grew to become a “serial acquirer” of that has spent $14 billion to acquire 55 companies during his tenure as CEO. 

Jun 17 2019

37mins

Play

We Hope to See You Next Week at the Medtech Conference

Podcast cover
Read more

Thank you for your support of the MedtechTalk Podcast. We hope to see you at the Medtech Conference next week. We’ll be posting compelling interviews with Medtech’s leaders immediately after the conference.   

May 24 2019

3mins

Play

GE Healthcare’s Agnes Berzsenyi Is Clearly Comfortable with Changing Women’s Healthcare

Podcast cover
Read more

In this week’s podcast, Agnes Berzsenyi, president and CEO of Women’s Health at GE Healthcare, explains how her upbringing in Hungary during a time of political upheaval put her in position to succeed in Medtech. The fall of the Berlin Wall – in addition to presenting a valuable life lesson - gave her the chance to study engineering in the US and secure a job at GE, first in the aviation business. But Berzsenyi’s desire to work for a purpose steered her to healthcare where she has overseen projects in ultrasound and mammography, including the release of the Senographe Pristina and Pristina Dueta, the industry’s first wireless remote that allows women to play an active role in their mammogram. Berzenyi says GE is designing with the patient in mind, creating a more comfortable breast screening procedure. She also talks about how her science-heavy upbringing in Hungary compares to the US where young women may not be steered as strongly toward STEM. She’s working to fix that as well.

May 17 2019

36mins

Play

Gelfand and Levin Share Lessons from Ardian’s Rise and Fall…and Rise Again. Would They Do It Again?

Podcast cover
Read more

Howard Levin and Mark Gelfand, the principals of Coridea, return to the podcast to detail the trials and tribulations of Ardian. Ardian is one of the bigger #medtech #startup stories over the past two decades. In 2011, Medtronic agreed to pay $800 million upfront for this company that pushed the once crazy idea of ablating renal nerves to lower hypertension. Ardian had raised $70 million from a syndicate of blue chip investors after being forged in the Foundry incubator. VCs proudly shared that the earnouts for Ardian would push that price well over $1 billion. This was a HUGE win for Medtech when it desperately needed it. 

Three years later came the fall. A day before JP Morgan’s Healthcare Meeting in 2014, Medtronic announced early disappointing of SYMPLICITY HTN-3, a third and larger trial of Ardian’s renal denervation.  Medtronic revised the trial, running Spryal HTN on patients who didn’t take any medication for their hypertension – a contrast from the Symplicity trial where patients were taking an average of five medications. In these revised trials, renal denervation is performing much better. 

The new results exonerated Ardian’s early backers – and perhaps Gelfand and Levin, specifically. This was the team, after all, that combed through medical libraries for clues about hacking the human body to beat back hypertension. The research turned up the discovery that surgeons once would treat extremely unresponsive hypertension by severing nerves near the kidney. 

The procedure worked, but it was dangerous. Levin and Gelfand saw ablating tissue as a safer path. And, after a lot of trudging up and down the Valley, finally found a willing partner in the team at The Foundry. Early clinical success led to a renal denervation gold rush. Nearly every VC and Strategic investor had a bet in this space.  

The 2014 debacle convinced many to close their programs and companies, but now Renal Denervation is back in favor.  

How did Howard Levin and Mark Gelfand enjoy the roller coaster ride? 

In this podcast, we’ll talk about Ardian, TAVR, the challenges facing Medtech VCs and the poor reception many surgeons give new interventional technologies.

May 06 2019

37mins

Play

Mark Gelfand, Howard Levin Discuss Coridea, Ardian and How They’re Innovating Medtech Innovation

Podcast cover
Read more

Over the past decade, no other Medtech start-up has moved markets as much or as quickly as Ardian, the godfather of the renal denervation surge a decade ago. But the gold rush dried up in 2014 when Medtronic delivered disappointing clinical trial news that left many to declare “Renal Denervation is Dead.” Well, if we may borrow from Monty Python, renal denervation is not dead yet.  In this two-part podcast, we talk with Mark Gelfand and Howard Levin, the principals of Coridea, who developed Ardian’s approach. We'll talk with them about their path to creating Coridea, the state of innovation, and, of course, how the Ardian “Opera” influenced them going forward.

Apr 29 2019

30mins

Play

Shyam Natarajan, CEO and Founder of Avenda Health, Explains How the Start-Up is Gaining Momentum

Podcast cover
Read more

In this episode of the MedtechTalk Podcast, we talk with Shyam Natarajan, PhD, founder and CEO of Avenda Health, a company using imaging, AI and focal lasers to create a better treatment for prostate cancer.  The company’s original co-founders – Natarajin and Dr. Leonard Marks -  started working on the company in earnest five years ago, but recently has begun getting real traction and making big moves. Natarajan talks  about the company’s origins, its unusual fundraising path, and its relatively short path to potential FDA Approval.

Apr 21 2019

31mins

Play

Nuvaira’s Dennis Wahr Gives Presenting Tips, IDs his Role Models, Talks About Possibly Going Public

Podcast cover
Read more

You’ll have a hard time finding a more modest man than Dennis Wahr, president and CEO of Nuvaira. But when asked what company he sees as being poised to establish the Interventional Pulmonology industry Wahr says Nuvaira might be the one. Nuvaira’s Targeted Lung Denervation, or TLD, is a non-surgical procedure that interrupts overactive nerve signals and may reduce obstructive airway symptoms, helping you to breathe easier. Could Nuvaira be the company to finally set the cement in the foundation of Interventional Pulmonology? Or will Nuvaira build upon the success of Pulmonx and Inspire, two other respiratory companies making great strides in commercializing new technology. In this podcast, Dennis Wahr discusses Nuvaira’s fund-raising success and what it means for its future (could an IPO be possible?) He also gives tips to other companies presenting at the May 17 Respiratory Innovation Summit in Dallas, another Healthegy-organized event. AttendRIS.com

Apr 12 2019

28mins

Play

Go Go Go! Scott Huennekens Explains How Strong Bias to Action Defined Leadership at Volcano, Verb

Podcast cover
Read more

Anyone who has swapped emails with Scott Huennekens has seen the Go Go Go signature at the bottom. They’re three little words, but they say so much about the special brand of enthusiasm Huennekens brings to leading companies like Digirad, Volcano, and most recently, Verb, the partnership between Google and Johnson & Johnson. In this podcast, Huennekens explains what he learned about maintaining momentum in Medtech. When is grit misplaced? When is hopping on a plane to Europe with no plan in hand a good idea? Huennekens will bring his insights to the Medtech Conference on May 29–30.

Apr 05 2019

49mins

Play

KPV’s Amy Belt Raimundo Landed in VC Just Before the Bottom Fell Out. Hear How She Pivoted, Thrived

Podcast cover
Read more

No, Amy Belt Raimundo didn’t blow anything up. But she knew early on in college that her initial career choice of chemistry wasn’t her true path. Instead, she earned an economics degree, and used insights learned to begin a stint in consulting. Those formative years led her to business school and a job at Guidant. In this podcast, Amy Belt Raimundo explains how asking the right questions at Guidant set her internal GPS toward a career in investing for venture firms, corporates, and now the most prominent healthcare system in the country.

Mar 29 2019

41mins

Play

iTunes Ratings

28 Ratings
Average Ratings
20
5
2
0
1

Great podcast

By Catherine.cookie - Jul 13 2019
Read more
Great for anyone looking to learn more about medical technologies/ current Med tech news

Medtech Investor

By MJ12345! - Mar 14 2019
Read more
Love the interview content. Well rounded and interesting. Always learn something new